Tag Archive for revenue 2024

PM-International Announces Records at Leadership Event 2024

PM-International set a new milestone with its Leadership Event 2024 in Berlin, Germany. Over 2,200 top Leaders from around the world gathered to discuss future strategies and celebrate achievements. This event marked the largest Leadership Event in the company’s history and underlined its continuous growth.

The Future of PM-International: “Big Things Are Coming,” Says Rolf Sorg.

CEO & Founder Rolf Sorg used the opportunity to give a glimpse into a significant product innovation in the range of FitLine nutritional supplements planned for 2025. He announced a “product revolution” with the potential to transform the nutritional supplement market and open new opportunities for PM-International’s distribution partners. While no details have been disclosed yet, the announcement and first product testimonials created noticable excitement among attendees.
In the direct sales industry, PM-International has established itself at the forefront. With retail sales of over USD 3 billion in the PM-International Group in 2023 and ranking 6th in the “DSN Global 100” list of the world’s largest direct selling companies, the company’s next goal is to join TOP5 of its industry. This growth reflects the immense dedication and commitment of PM-International’s distribution partners
worldwide.
€2,376,000 for Children in Need
PM-International continues to share its success. A significant moment of the event

Read more...

Olive Tree People Surpassing $3.7 Million In Daily Sales

Oliveda International, Inc. (OTC Pink: OLVI) today announced that its Olive Tree People Inc. subsidiary exceeded the $2 million daily sales mark for the first time in September 2024, and last Friday, just 21 months after launching in the United States, the Company exceeded $3.7 million in daily sales, and the trend is still rising.
When asked how the enormous growth is managed within such a short time and whether this is handled with the help of third-party providers, founder and CEO Thomas Lommel replied,

“Twenty-one months ago, we started packing the first 40 packages a day in my garage in Venice Beach, and then, within just a few months, we built our own distribution and logistics center next to our offices in Venice Beach, with which we can produce and ship over 20,000 packages per day.
We are proud not to use third-party providers, but to have built everything ourselves from scratch over the past few months here in the U.S. We believe it is important to maintain very close and direct contact with our beloved customers and consultants.”

Mr. Lommel also commented on the secret of the Olive Tree People’s exponential growth here in the U.S.

“Twenty-one years deeply believing in our olive

Read more...

LR Health & Beauty Revenue Q3 Up 7.2% To Euro 69.4 Million

LR Health & Beauty SE, Europe’s leading digital social commerce company in the area of high-quality nutritional supplements and cosmetic products, today published its figures for the third quarter of 2024 and the first nine months of 2024.

Despite the challenging market environment, LR Health & Beauty SE increased sales (revenue from goods sold) by 7.2% to EUR 69.4 million in the third quarter of 2024 (Q3 2023: EUR 64.7 million).

This resulted in sales for the first nine months of 2024 of EUR 212.7 million compared to EUR 205.6 million in the previous year, an increase of 3.4%. The recent market launch of the cosmetic product range LR ZEITGARD Signature and the realignment of the career plan for distributors made a major contribution to sales growth.
On top of that, EBITDA reported increased in the third quarter of 2024 to EUR 7.3 million compared to EUR 7.1 million in the third quarter of the previous year. As a result, EBITDA reported in the first nine months of 2024 totaled EUR 19.0 million compared to EUR 22.4 million in the prior year period.
Normalized EBITDA increased sharply from EUR 7.7 million in the third quarter of the previous year to EUR 8.7 million

Read more...

Zinzino Q3 Revenue Up 22% To Approx. $48 Million Or SEK 532.8 Million

All below figures in Swedish Kronor:
Revenues in the third quarter of 2024 amounted to SEK 532.8 (436.9) million, corresponding to 22% (25%) growth compared to the corresponding period last year.
In local currencies, revenues increased by 24% compared to the third quarter of the previous year. EBITDA profit amounted to SEK 63.0 (71.2) million and the EBITDA margin was 11.8% (16.3%).
The EBITDA margin was compared to a very strong third quarter last year and the change was mainly due to the marginally weaker gross profit for the quarter because of increased raw material prices and normalized distributor compensation.
In addition, increased sales costs linked to acquisitions and expansion, combined with currency translation effects, had a negative impact of SEK -4.2 (3.9) million on EBITDA for the quarter. During the quarter, the company expanded its establishment in France following strong sales growth linked to the acquisition of assets of Xelliss.
After the end of the quarter, the new product Collagen Boozt was launched as well as the Canary Islands achieved full market status. This put the Islands on an equal footing with mainland Spain and other European markets. Accumulated total revenue for Q1-Q3 amounted to SEK 1,494.3 (1,238.5) million, corresponding to growth of 21% (22%), accumulated EBITDA of SEK 177.8 (169.3) million and an EBITDA margin of

Read more...

USANA Q2 Revenue 11% Down To $213 Million

USANA Health Sciences, Inc.announced financial results for its fiscal second quarter ended June 29, 2024.
Key Financial & Operating Results

Second quarter net sales were $213 million versus $238 million during Q2 2023.
Second quarter diluted EPS was $0.54 as compared with $0.89 during Q2 2023.
Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 million to $880 million and $2.40 to $2.55 (previously $850 million to $920 million and $2.40 to $3.00).

“Second quarter operating results were below our expectations,”

said Jim Brown, President and Chief Executive Officer.

“Ongoing macroeconomic pressures in several of our key markets continue to impact consumer spending. This in turn creates challenges in our ability to attract and engage new customers and generate sales momentum.
To counter these challenges, we have made several strategic changes in our business over the past few quarters, including (i) restructuring our commercial team, (ii) heightening our focus on product innovation, (iii) increasing our efforts to engage our sales leaders with an Associate-first approach, (iv) expanding into India, and (v) evaluating more business development activities.
“Next month, we will be hosting our Americas & Europe Convention in Las Vegas, Nevada along with other Associate engagement-focused events in the back half of the

Read more...

Zinzino First Half Year Sales Up 20% To Euro 801,6 Million

Revenues in the second quarter of 2024 amounted to SEK 507.0 (407.9) million, corresponding to 24% (24%) growth compared to the corresponding period last year. EBITDA increased to SEK 63.0 (53.7) million, and the EBITDA margin amounted to 12.4% (13.2%).
During the quarter, Zinzino acquired the rights to Luxembourg-based Xelliss SA distributor database, inventory and IP assets, acquired 49% of the shares in the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD and signed a letter of intent to acquire the US direct sales company Zurvita INC. In addition, the launch of Serbia was announced as the next step in the global expansion.
APRIL-JUNE
• Total revenue amounted to SEK 507.0 (407.9) million, corresponding to a growth of 24% (24%)
• Gross profit amounted to SEK 174.5 (148.5) million and the gross profit margin amounted to 34.4% (36.4%)
• EBITDA profit amounted to SEK 63.0 (53.7) million and the EBITDA margin amounted to 12.4% (13.2%)
• Cash flow from operating activities amounted to SEK 91.1 (46.3) million
JANUARY-JUNE
• Total revenue amounted to SEK 961.6 (801.6) million, corresponding to a growth of 20% (21%)
• Gross profit amounted to SEK 335.4 (279.2) million, and the gross profit margin amounted to 34.9% (34.8%)
• EBITDA profit amounted to SEK 114.7 (98.1) million,

Read more...

USA Q2 Revenue 2024 Down 11% To $ 213 Million

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 29, 2024.
Key Financial & Operating Results

Second quarter net sales were $213 million versus $238 million during Q2 2023.
Second quarter diluted EPS was $0.54 as compared with $0.89 during Q2 2023.
Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 million to $880 million and $2.40 to $2.55 (previously $850 million to $920 million and $2.40 to $3.00).

“Second quarter operating results were below our expectations,”

said Jim Brown, President and Chief Executive Officer.

“Ongoing macroeconomic pressures in several of our key markets continue to impact consumer spending. This in turn creates challenges in our ability to attract and engage new customers and generate sales momentum.
To counter these challenges, we have made several strategic changes in our business over the past few quarters, including (i) restructuring our commercial team, (ii) heightening our focus on product innovation, (iii) increasing our efforts to engage our sales leaders with an Associate-first approach, (iv) expanding into India, and (v) evaluating more business development activities.
“Next month, we will be hosting our Americas & Europe Convention in Las Vegas, Nevada along with other Associate engagement-focused events in the back half of the year. We are also planning to offer a more robust promotional calendar throughout the remainder of the year.”

Balance Sheet and Share Repurchase Activity
The Company generated $8 million in operating

Read more...

Zinzino January 2024 Revenue Up 15% To $14 Million

According to a Zinzino press release:
Zinzino group revenue increased with a total of 15%, compared with the previous year.
The revenue in January for Zinzino’s sales markets increased by 17% and amounted to SEK 140.2 (120.3) million.
Faun Pharma’s external sales decreased by 11% and amounted to SEK 8.1 (9.1) million.

Overall, the Group increased revenues by 15% to SEK 148.3 (129.4) million compared with the previous year.

About Zinzino
Zinzino AB (publ.) is a global Direct Sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the research unit BioActive Foods AS and production unit Faun Pharma AS.
Zinzino is based in Gothenburg, with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong and Malaysia. Zinzino is a public company and its shares are listed on Nasdaq First North Premier Growth Market. For more informaton please visit www.zinzino.com
 
The post Zinzino January 2024 Revenue Up 15% To $14 Million appeared first on Direct Selling Facts, Figures and News.

Read more...